Introducing CSAN® Pronto™, the newest innovation of
the CSAN® program
Provides laboratory-accurate WBC counts and NEUT% in real time
Requires only 1 drop of capillary blood (about 3.5 μl) to run the test1
Offers one-step processing, while maintaining CSAN®’s privacy standards1,2
Is designed to address a barrier of CLOZARIL® use by offering the convenience of onsite testing
Dear Healthcare Professional,
CSAN® (CLOZARIL® Support and Assistance Network) is a comprehensive support and blood monitoring program that has assured the safe use of CLOZARIL® for Canadians since 1991.
The CSAN® program is offering a new way to help simplify the routine bloodwork of patients on CLOZARIL®.²
We are proud to announce the launch of CSAN® Pronto™ in Canada!
CSAN® Pronto™ is a new point-of-care device indicated for quantitative determination of WBC and NEUT% in capillary blood or K2EDTA venous whole blood. CSAN® Pronto™ is indicated for in vitro diagnostic use only in clinical laboratory and point-of-care settings by trained healthcare professionals in adult patients. Patients’ results can be provided to your healthcare team in real time and are simultaneously auto- uploaded into your patients’ CSAN® profile using the CSAN Patient Care Portal®.1,2
To learn more, watch the video about this new addition to the CSAN® program, or contact the CSAN® team at 1-800-267-2726